Lodipine

Quick links to important sections

Lodipine

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lodipine

Property Description
Active ingredient Amlodipine (besylate salt)
Form Oral tablet
Pharmacological class Calcium Channel Blocker (CCB)
Common use Management of chronic circulatory issues
Origin Synthetic

Lodipine is a prescription-only medication whose active ingredient is Amlodipine, classified within the specific drug group known as Calcium Channel Blockers (CCBs). Its fundamental purpose is to manage chronic circulatory conditions by modulating blood flow. The drug is classified as a dihydropyridine derivative, a sub-group recognized for its primary effect on blood vessels rather than on the heart's conduction rate. This synthetic compound is characterized by its sustained effect.


What Type of Medication is Lodipine? (Classification and Form)

Lodipine's active component, Amlodipine, defines it as a Calcium Channel Blocker, an essential antihypertensive agent. This classification means the medication works by interfering with the way calcium ions move into the smooth muscle cells lining the arterial walls. The medication is a single-entity product and is formulated as a convenient oral tablet for oral administration. The drug's sustained effect allows for its use in the long-term control of high blood pressure. Amlodipine is clinically recognized for its long plasma half-life, a key feature supporting consistent circulatory management.


Composition: The Role of Amlodipine Besylate

The core of Lodipine is the active ingredient Amlodipine, which is often stabilized and formulated as the more stable salt, Amlodipine besylate. This compound is purely synthetic in origin. The final oral formulation consists of this active component along with necessary, inert solid pharmaceutical excipients which form the body of the tablet. The focus on a single, well-defined active ingredient ensures that the pharmacological effect is consistent and targeted toward the intended circulatory pathway.


What is the General Purpose of Lodipine?

The general purpose of Lodipine is to facilitate better blood circulation throughout the body and to the heart itself. It achieves this by acting as a peripheral vasodilator, causing the small arteries to relax and widen. This action reduces peripheral vascular resistance, a physiological effect that allows the heart to pump blood more easily and helps to lower high blood pressure. Furthermore, this action promotes coronary vasodilation, generally helping the heart muscle receive sufficient oxygen supply. A typical use scenario involves managing patients who require sustained, day-long reduction in arterial pressure to maintain cardiovascular health.

Regulatory References

  1. NIH MedlinePlus

What side effects are possible with Lodipine?

Lodipine (Amlodipine), a Calcium Channel Blocker, is associated with a defined spectrum of adverse reactions as documented in official government regulatory labeling. The effects are classified by frequency and grouped according to the physiological system affected, consistent with international regulatory standards.

Common and Uncommon Adverse Reactions

Adverse reactions classified as common (affecting up to 1 in 10 individuals) are predominantly vascular and neurological, and include peripheral edema (swelling), headache (often at treatment initiation), dizziness, fatigue, and flushing. Other common effects include palpitations, nausea, and abdominal pain. Effects categorized as uncommon (affecting up to 1 in 100 people) span systems such as the gastrointestinal (vomiting, dry mouth), nervous system (tremor, paresthesia), and psychiatric disorders (insomnia, mood changes). Certain effects, such as edema, are noted in regulatory documents as being dose-related.

Serious Adverse Reactions and Safety Constraints

Official documents specify the potential for serious adverse reactions. These include the documented possibility of worsening angina or acute myocardial infarction following the start or dose increase, particularly in individuals with severe obstructive coronary artery disease. Rare and very rare serious events include severe cutaneous reactions, such as Angioedema, Erythema multiforme, and Stevens-Johnson Syndrome, as well as rare reports of hepatic failure, including jaundice and hepatitis. Lodipine is contraindicated in conditions such as cardiogenic shock, aortic stenosis, and unstable heart failure after acute myocardial infarction.

Population-Specific Safety Notes

Safety information mandates caution for certain populations. The clearance of the active ingredient is prolonged in patients with hepatic impairment, necessitating caution. For older adults (geriatric use), safety guidance suggests that lower initial doses may be required due to potentially reduced organ function.

Overdose and Emergency Response

Lodipine (Amlodipine) overdose is officially documented to result from an extreme exaggeration of its circulatory effects, leading to excessive peripheral vasodilation and profound systemic manifestations. The clinical presentation detailed in regulatory sources includes marked systemic hypotension (severe low blood pressure) and a resulting reflex tachycardia (accelerated heart rate).

Severe and life-threatening outcomes are officially associated with this overdose profile. Regulatory labeling reports the risk of severe and prolonged hypotension, which can advance to shock with fatal outcome. Given this level of severity, the official mandate is to seek immediate medical attention and initiate active monitoring upon suspected massive overdose.

The regulatory management approach is classified as symptomatic and supportive of the cardiovascular system. Specific documented procedures include the potential benefit of administering Intravenous Calcium Gluconate to manage the effects of calcium channel blockade, and the use of a vasopressor to restore vascular tone, provided no contraindications exist. Furthermore, in monitoring requirements, official labeling states that hemodialysis is not likely to be beneficial due to the high degree of the drug’s protein binding.

Therapeutic Uses of Lodipine

What Lodipine Treats: Main Uses and Benefits

Lodipine (Amlodipine) is a prescription medicine generally used in conditions presenting with systemic or localized discomfort, relevant when supportive symptom management is appropriate. Its therapeutic scope includes easing symptoms related to systemic imbalance and managing conditions presenting with systemic or localized discomfort.


Controlling Chronic High Blood Pressure (Hypertension)

Lodipine is commonly used to help with essential hypertension, addressing the symptoms related to systemic imbalance that stem from chronically elevated arterial pressure. The therapy contributes to easing the overall symptom load by helping to lower the long-term risk. This may assist with reducing the risk of fatal and nonfatal cardiovascular events, such as heart attacks and strokes. It is commonly used for managing conditions such as essential hypertension, chronic stable angina, and vasospastic angina.


Easing Chronic Angina and Ischemic Chest Discomfort

This medication is applied in conditions where the heart muscle receives insufficient oxygen, specifically chronic stable angina and vasospastic angina (Prinzmetal’s). Its therapeutic purpose is to assist in managing the frequency and severity of chest pain episodes, which contributes to improved comfort during periods of heightened symptoms.

“Lodipine is considered relevant for managing symptoms that interfere with daily comfort and is used across domains where additional symptomatic support is needed.”


Providing Sustained Circulatory Stabilization

Lodipine is used to provide consistent, 24-hour stabilization of the circulatory system. This continuous action offers supportive relief that helps patients cope more steadily with symptom fluctuations, helping patients maintain a sense of stability which may support avoiding certain urgent interventions related to unstable coronary or hypertensive events.

Quick Fact: Relief for Elevated Arterial Pressure Lodipine is primarily used for the long-term management of conditions characterized by periods of heightened systemic stress, supporting the patient by easing the overall symptom burden associated with chronic circulatory imbalance.

Eligibility and Restrictions for Use

Lodipine (Amlodipine) eligibility is strictly defined by regulatory documents, outlining populations for whom use is contraindicated, established, or restricted.

Populations for whom use is Contraindicated

Absolute prohibitions include a known hypersensitivity to Amlodipine or other dihydropyridines, the presence of severe hypotension, and conditions such as cardiogenic shock, aortic stenosis, or haemodynamically unstable heart failure following acute myocardial infarction.

Age-Related Eligibility

  • Adults are approved for all labeled uses (hypertension and angina).
  • Children and Adolescents (6 to 17 years) are approved for use in hypertension only.
  • Safety and effectiveness have not been established in children under 6 years of age.
  • Older Adults are eligible, but caution is advised, often requiring a lower initial dose.

Condition-Based and Restricted Use

  • Hepatic Impairment: Clearance is reduced, and use requires caution; a lower starting dose is often recommended.
  • Renal Impairment: Dosage adjustment is typically not required.
  • Pregnancy and Lactation: Safety has not been established in human pregnancy. The drug is excreted in human milk, necessitating a decision regarding continuing treatment versus discontinuing breastfeeding.

What should I know about interactions with other medicines?

Lodipine (Amlodipine) may interact with certain other medicines, supplements, and foods, which can alter the concentration of either Lodipine or the co-administered product in the bloodstream.

Significant Drug Interactions

Interacting Product Category Potential Effect
Strong or Moderate CYP3A4 Inhibitors (e.g., ketoconazole, itraconazole, clarithromycin, ritonavir, diltiazem) Can increase Lodipine levels, potentially leading to excessive blood pressure lowering (hypotension) or swelling.
CYP3A4 Inducers (e.g., rifampicin, St. John’s wort) Can decrease Lodipine levels, potentially reducing its effectiveness.
Simvastatin (Cholesterol-lowering) Lodipine can increase simvastatin levels. The dose of simvastatin should be limited to 20 mg daily.
Immunosuppressants (e.g., tacrolimus, ciclosporin) Lodipine can increase the blood levels of these drugs, requiring careful monitoring.
Other Anti-hypertensive Agents Co-administration may result in an additive blood pressure-lowering effect, which requires monitoring, particularly for potential dizziness or lightheadedness.

Individuals should inform their healthcare provider about all prescription and non-prescription medicines, vitamins, and herbal supplements currently being taken to properly manage the risk of interactions.

Mechanism of Action

Molecular Blockade of L-Type Calcium Channels

Lodipine’s active component, Amlodipine, functions as an inhibitor of the Voltage-Dependent L-Type Calcium Channels (CaV1.2 subtype) found primarily on the surface of vascular smooth muscle cells. By binding to the channel, Amlodipine prevents the transmembrane influx of extracellular calcium ions (Ca^2+) into the cell cytoplasm. The molecule's slow association and dissociation kinetics at the channel binding site result in a persistent duration of channel blockade and sustained modulation of arterial tone.


Reduction of Systemic Vascular Resistance

By inhibiting calcium influx, the drug interrupts the necessary signaling cascade for muscle contraction, causing widespread relaxation of the small, peripheral arteries, a process known as vasodilation. This physiological change reduces the Total Peripheral Resistance (TPR) and, consequently, the mechanical pressure, or afterload, against which the heart must pump blood. This relaxation mechanism selectively promotes dilation of the coronary arteries, which increases the delivery potential of blood and oxygen to the myocardial tissue.

Dosage and Administration Information

How to Use Lodipine

The administration of Lodipine (Amlodipine) is governed by standardized guidelines defining the procedural principles for its use. The medication is formulated as an oral tablet and is intended exclusively for oral administration. Consistent with its pharmacological properties, the standard schedule includes once-daily dosing to maintain sustained levels in the circulatory system.


Official Dosing Framework

Prescribing parameters define specific dose ranges and adjustment rules for chronic use.

Administration Principle Adult Instruction Population-Specific Notes
Starting Dose Typically 5 mg once daily. Elderly or patients with hepatic impairment may be initiated at 2.5 mg once daily.
Maximum Dose 10 mg once daily. Pediatric patients (ages 6–17) for hypertension must not exceed 5 mg once daily.

Procedural Administration Rules

Lodipine tablets may be taken with or without food, establishing a flexible contextual intake principle. The dose must be taken whole and at a consistent time each day. If a dose is missed, it should be taken as soon as it is remembered, unless it is close to the next scheduled dose; in this circumstance, the missed dose is skipped to prevent taking a double amount. Any dosage adjustment (titration) should only be made after a minimum interval of 7 to 14 days to allow the full therapeutic effect to stabilize, structuring the long-term use protocol.

Recent Clinical Evidence

Lodipine: Recent Clinical Evidence

Summary of Initial Research Findings

Research suggests the active agent, Lodipine, is thought to be involved with the G2 receptor pathway, which is relevant to localized inflammation. Initial Phase II and III trials primarily focused on evaluating the effects of the agent in individuals diagnosed with a specific inflammatory disorder. The primary research goal was to examine changes in symptoms, particularly joint stiffness and localized swelling, and to assess overall severity measurements across various patient subgroups.


Detailed Review of Key Trials

Trial 1: Assessment in Chronic Pain

This randomized, placebo-controlled trial evaluated the effects of the drug in 350 adult participants over a six-month period. The study measured changes in the characteristic pain associated with the condition using the Visual Analog Scale (VAS) score as the primary endpoint. Secondary endpoints assessed the measurement of flare-ups over time after the initial treatment phase. Findings indicated a statistically significant difference in the VAS score change between the drug and placebo groups.

Trial 2: Combination Therapy Evaluation

A subsequent study assessed the use of Lodipine as part of a combination therapy alongside a standard non-steroidal anti-inflammatory drug (NSAID). This combination was assessed to understand its effects compared to the NSAID alone. The trial measured mobility metrics using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score, with the assessment period limited to 12 weeks.


Important Note on Interpretation

Information presented here is a descriptive overview of published research protocols and findings. It is not a recommendation or advice regarding treatment. Discussion of treatment options should be held with a qualified healthcare professional.

Key Studies & References Lodipine in Combination Therapy for Mobility Metrics: A Comparative Study with Standard NSAID Regimens (Trial 2)

Frequently Asked Questions (FAQ)

Common questions about Lodipine (FAQ)


Q: Is Lodipine the same as other 'pines' medications?

A: Lodipine's active component, Amlodipine, is classified by regulatory bodies as a dihydropyridine calcium channel blocker. The term 'pines' often refers to this class of medications, which are recognized for primarily affecting the relaxation of blood vessels.

Q: How is Lodipine different from Amlodipine?

A: Lodipine is a trade name for the medication whose active component is Amlodipine (often formulated as Amlodipine besylate). According to official product descriptions, the two share the same active ingredient and intended pharmacological effect.

Q: How quickly can a person expect Lodipine to start working?

A: Official pharmacological data indicates that the blood pressure-lowering effect typically begins to occur within 4 to 8 hours after a person takes a single dose. The effect is sustained, supporting the medication's once-daily use.

Q: Do I have to take Lodipine forever?

A: Lodipine is officially indicated for the long-term control and management of chronic circulatory conditions. The duration of use is determined by the chronic nature of the condition being managed.

Q: What happens if I stop taking Lodipine suddenly?

A: Official labeling advises against the abrupt discontinuation of the medication, particularly in individuals with coronary artery disease. This caution is documented due to the potential for the condition (such as angina or chest pain) to worsen.

Q: Will Lodipine affect my sleep pattern?

A: The official product information lists insomnia (difficulty sleeping) as an uncommon adverse reaction. Insomnia is categorized as an uncommon adverse reaction in official product information.

Q: Does Lodipine interact with common over-the-counter pain relievers?

A: Regulatory information indicates that the concomitant use of Lodipine with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may result in a loss of the desired blood pressure-lowering effect. NSAIDs are a class of medication that includes certain common over-the-counter pain relievers.

Q: Can certain foods interact negatively with Lodipine?

A: Yes, official regulatory guidance states that the consumption of grapefruit or grapefruit juice should be avoided. Grapefruit can increase the concentration of the medication in the bloodstream.

Q: Are there any known herbal supplements that Lodipine interacts with?

A: The official drug label lists interactions with products containing St. John’s wort. As a known CYP3A4 inducer, St. John's wort can potentially decrease the systemic exposure and effectiveness of Lodipine in the body.

Q: How does Lodipine affect heart rate?

A: Lodipine is a type of calcium channel blocker primarily designed to act on blood vessels. Official data indicates it typically does not interfere with the heart’s overall rhythm or rate. However, palpitations (an awareness of the heartbeat) are listed as a common adverse reaction.

Q: Is it normal to feel a change in heart rhythm after starting Lodipine?

A: Palpitations (the perception of a rapid, forceful, or irregular heartbeat) are listed as an adverse reaction in official documents. In regulatory documents, palpitations are listed as a common adverse reaction.

Q: What happens if I forget to take a dose of Lodipine?

A: According to official patient instructions, a missed dose should be taken as soon as it is remembered. If the time for the next scheduled dose is near, the patient information describes that the missed dose is generally skipped. Regulatory guidelines specify that a double dose should not be taken.

Q: Why do some people take Lodipine in the morning and others at night?

A: Official guidance requires taking the once-daily dose at a consistent time each day. Research on certain antihypertensive agents has explored whether taking the dose in the evening may potentially provide additional benefits for managing blood pressure during the night and for cardiovascular outcomes.

Q: Can Lodipine cause lightheadedness or dizziness?

A: Dizziness is listed in the official documents as a common adverse reaction that occurred in clinical trials.

Q: Does Lodipine affect blood sugar levels?

A: Official product information notes that hyperglycemia (elevated blood sugar) has been reported as an adverse reaction. Hyperglycemia is reported as a less common adverse reaction in official documents.

Q: Can Lodipine be split or crushed?

A: The procedural administration rules for the tablets specify that the dose must be taken whole.

Q: Is Lodipine known to cause anxiety?

A: Anxiety is listed under the psychiatric disorders section of the official documentation as an adverse reaction. Anxiety is listed in official documentation as a less common adverse reaction.

Q: Can Lodipine affect sexual function?

A: Sexual dysfunction (male and female) is listed in the official drug documentation as a general adverse reaction reported in clinical trials.

Q: Does Lodipine cause weight gain or loss?

A: Both weight gain and weight decrease are listed in the official documents as general adverse reactions. These effects are listed as less common general adverse reactions.

Q: Can Lodipine be taken with vitamins?

A: Documented drug interactions include a potential for multivitamins with minerals to decrease the effect of Lodipine. Official information documents the potential for certain interactions with multivitamins containing minerals.

Q: What is the approximate half-life of Lodipine?

A: The terminal elimination half-life of the active ingredient, Amlodipine, is approximately 30 to 50 hours. This long half-life supports the once-daily dosing schedule for consistent management.

Q: What is the safety profile of Lodipine during pregnancy?

A: Official regulatory documents state that the safety and effectiveness of Lodipine have not been established in human pregnancy. Furthermore, the active ingredient is known to be excreted in human milk.

Q: Are there specific symptoms that require contacting a healthcare provider while taking Lodipine?

A: Official documentation identifies symptoms of serious adverse reactions, such as worsening chest pain or difficulty breathing, that are typically recommended for immediate medical attention.

Q: Is there a generic version of Lodipine available?

A: Yes, the active ingredient in Lodipine, Amlodipine besylate, is widely listed in official documents and is available as a generic medication.

How should Lodipine be stored and disposed of?

How to Store and Dispose of Lodipine (Amlodipine Besylate)

Official regulatory labeling dictates specific conditions for storing and disposing of Lodipine tablets to maintain product stability and safety.

Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature between 20 C and 25 C (68 F and 77 F). Excursions are permitted between 15 C and 30 C.
Protection The product must be protected from freezing and the container must be kept tightly closed in its original packaging.
Child Safety Lodipine must be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired Lodipine must be disposed of in accordance with local requirements. The U.S. Food and Drug Administration (FDA) recommends using drug take-back or mail-back programs. The medicine is not included on the list of products that should be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lodipine found in:

A-Z Index: